首页> 外文期刊>Analytical and bioanalytical chemistry >LC-MS analysis and environmental risk of lipid regulators
【24h】

LC-MS analysis and environmental risk of lipid regulators

机译:LC-MS分析和脂质调节剂的环境风险

获取原文
获取原文并翻译 | 示例
           

摘要

This article presents a review of liquid chromatography-mass spectrometric (LC-MS) methods applied to the determination of lipid-regulating agents, "fibrate" and "statin" classes, and some of their metabolites (clofibric acid and fenofibric acid) in environmental samples. Concentration levels of this therapeutical group have been reported in the ppt to ppb range for different compartments (wastewater, surface water and sediments) in several monitoring studies. Part of this article is dedicated to hazard assessment of lipid-regulating agents according to the approaches of the European Union (EU) and Environmental Protection Agency (EPA) for identifying persistent, bioaccumulable and toxic (PBT) substances. The pharmacodynamic and pharmacokinetic activities of these pharmaceuticals are well known and, based on this information, the derivation of the potential long-term effects, which may be induced on eco-organisms at low concentration levels, is discussed. Studies of environmental risk assessment (ERA) for lipid regulators carried out through the framework of the European Agency for the Evaluation of Medicinal Products (EMEA) and Food and Drug Administration (FDA) are presented.
机译:本文介绍了液相色谱-质谱(LC-MS)方法的应用,这些方法用于测定环境中的脂质调节剂,“贝特”和“他汀”类及其某些代谢物(氯纤维酸和非诺贝酸)样品。在几项监测研究中,不同隔室(废水,地表水和沉积物)的治疗组浓度水平已在ppt至ppb范围内报告。本文的一部分专门根据欧盟(EU)和环境保护局(EPA)的方法对脂质调节剂进行危害评估,以鉴定持久性,可生物积累和有毒(PBT)的物质。这些药物的药效学和药代动力学活性是众所周知的,并且基于该信息,讨论了在低浓度水平下可能对生态生物产生的潜在长期影响。本文介绍了通过欧洲药品评估机构(EMEA)和食品药物管理局(FDA)进行的脂质调节剂环境风险评估(ERA)研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号